One year ago, we heard about the work of researchers with Rice University, who used an OpenSLS 3D printer to develop 3D printed lattices for bone tissue engineering. The researchers began their work in late 2015, and have been hard at work studying 3D printed bone tissue scaffolding. Rice bioengineer Antonios Mikos is leading the research team, and they’ve enhanced their original 3D printed scaffold, in an effort to make it more sophisticated, so they can better study how Ewing’s sarcoma (ES, a pediatric bone cancer) cells respond to stimuli, such as shear stress (the force that tumors experience when viscous fluids flow through the bone). These scientists have concluded that a scaffold structure, whether it’s natural or not, does in fact have an effect on how “cells express signaling proteins that help cancer grow.”
This means that if 3D printed materials can be designed to better determine how tumors generate, then it may become easier to test treatments for bone cancer. Scaffold porosity, which is the percent of empty space created by pores in a structure, along with the size and shape of pores, can change the permeability of nutrients and media, impact cell attachment, and even facilitate cell migration. According to the Rice University scientists, 3D printing lets them get closer than ever before to impersonating the architecture of actual bone. This research was recently published in a paper, titled “Effects of shear stress gradients on Ewing sarcoma cells using 3D printed scaffolds and flow perfusion” in the American Chemical Society journal ACS Biomaterials Science and Engineering.
According to the research paper’s abstract, “As cancer biologists elucidate the relevance of 3D in vitro tumor models within the drug discovery pipeline, it has become more compelling to model the tumor microenvironment and its impact on tumor cells. In particular, permeability gradients within solid tumors are inherently complex and difficult to accurately model in vitro. However, 3D printing can be used to design scaffolds with complex architecture, and flow perfusion can simulate mechanical stimulation within the tumor microenvironment. By modeling these gradients in vitro with 3D printed scaffolds and flow perfusion, we can identify potential diffusional limitations of drug delivery within a tumor.”
According to Mikos, what’s really special is the scaffold itself: the 3D printed, bone-like polymer has different sizes of pores to “constrain fluids” that flow through, which, depending on the orientation of the scaffold, will apply different degrees of shear stress to the actual tumor cells.
By making changes to the architecture of the scaffold, Mikos said they are able to vary the mechanical environment where the fluids flow, which also changes the “magnitude of shear stress exerted on tumor cells.”
Mikos said, “We aim to develop tumor models that can capture the complexity of tumors in vitro and can be used for drug testing, thus providing a platform for drug development while reducing the associated cost.”
The scaffolding was 3D printed in flat sections, with pores measuring 0.2 mm, 0.6 mm, and 1.0 mm. Each 3D scaffold, seeded with tumor cells, was built by stacking three layers on top of each other. In order to make the simulations more realistic than cells growing in a regular petri dish, the scaffolds were put into a flow perfusion reactor, which mimics a biological environment by the push and pull of both tissues and fluid. The researchers discovered that the cells placed in conditions with zero fluid flow proliferated worse than the cells under flow.
The layers of scaffolding with the smallest pores showed much more proliferation once the viscous fluid began flowing; the smallest pores restrict permeability, so it seems to me, and I am not a scientist, like the cells would just bunch up together instead of going through the pores. The scientists also discovered that the cells under fluid flow had an increase in production of an insulin-like growth factor protetin, or IGF-1, which is a “ligand on the surface of sarcoma cells and part of the signaling pathway that plays a critical role in resistance to chemotherapy.” The orientation of the three different pore sizes was also a factor in how much IGF-1 was produced by the cells.
Researchers suspect that the different levels of protein production came about due to the combination of scaffold orientation and shear stress. The plan is to study metastasis, and the response of test tumors to drugs, once the scaffold-printing process has been refined a little more. The lead authors of the study are two Rice alumni: Jordan Trachtenburg, who’s now an independent contractor at Rice, and Marco Santoro, who was involved with the original 2015 research and is now a faculty research associate at the University of Maryland.
The conclusion of the paper’s abstract reads, “Our results highlight how 3D printed scaffolds, in combination with flow perfusion in vitro, can effectively model aspects of solid tumor heterogeneity for future drug testing and customized patient therapies.”
The other co-authors of the paper are:
- Rice University: graduate students Brandon Smith and Eric Molina
- University of Oklahoma: graduate student Cortes Williams and Professor Vassilios Sikavitsas
- University of Maryland: graduate student Charlotte Piard and Fischell Family Distinguished Professor John Fisher
- University of California, San Diego: postdoctoral researcher Jesse Placone
- University of Texas MD Anderson Cancer Center: research assistant Brian Menegaz, senior research scientist Salah-Eddine Lamhamedi-Cherradi, and Associate Professor Joseph Ludwig
The Howard Hughes Medical Institute, the National Science Foundation, the National Institutes of Health, and the Armed Forces Institute of Regenerative Medicine all supported this research. Discuss in the Rice University forum at 3DPB.com.[Source: Rice University]